Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
As type 2 diabetes becomes more common among women of childbearing age and as GLP-1 receptor agonists such as semaglutide (Wegovy, Ozempic) are approved to treat obesity, the number of exposed pregnancies is likely to increase
Regular follow-up appointments are essential during GLP-1 therapy, typically aligning with the medication's titration schedule (often every 4 weeks initially) and as clinically indicated
GLP1 medications were first developed as injections because digestive enzymes can break down the active compounds before they enter the bloodstream
Working with a clinician who specializes in weight care can help you develop a personalized approach, with or without GLP-1 medication
US$ 28.78
US$ 20.49
US$ 23.35
US$ 22.02
